第一金融网主办
»您现在的位置: 第一金融网 >> 财经金融 >> 文传商讯 >> 正文

Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health

2023/4/21  文章来源:第一金融网  作者:文传商讯
文章简介: ThenewstrategiccollaborationwillincludesupportingBioInnovationInstitute(BII)tosourceandpotentiallyfundearly-stagestart-upsandprojects,specificallywithinthef

The new strategic collaboration will include supporting BioInnovation Institute (BII) to source and potentially fund early-stage start-ups and projects, specifically within the field of reproductive medicine
This collaboration helps to fill a gap, given that only 1% of healthcare research funding is invested in female-specific conditions beyond oncology1

SAINT-PREX, Switzerland -- (BUSINESS WIRE) --

Ferring Pharmaceuticals and BioInnovation announce a new strategic collaboration to accelerate innovation in women’s health.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230418005217/en/

BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals A/S (Ferring) have expanded their collaboration with the objective to accelerate world-class life science innovation within women’s health. New activities will include supporting BII to source, and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine.

The new strategic collaboration, highlights Ferring’s continued commitment to invest in early-stage innovation in this area, and we look forward to strengthening our collaboration with BII to accelerate new solutions for patients,” says Armin Metzger, Executive Vice President and Chief Science Officer at Ferring.

The strategic collaboration builds on Ferring’s engagement with BII’s Women’s Health Initiative through Ferring’s membership on the BII Women’s Health Innovation Panel. Women’s health is underserved as only 1% of global healthcare research funding is invested in female-specific conditions beyond oncology.1 The collaboration aims to bridge the gap by supporting early-stage innovation and will leverage BII’s proven expertise in translational science incubation, together with Ferring’s expertise in early-stage development and reproductive medicine.

Combining BII’s already proven incubation expertise with the industrial expertise and deep insights that Ferring has within women’s health forms a very strong basis for supporting and accelerating our mission of getting more solutions on the market that address the high unmet needs of 50% of the world’s population. We are pleased to collaborate even closer with Ferring to make it happen,” says Trine Bartholdy, Chief Innovation Officer at the BioInnovation Institute.

About Ferring Pharmaceuticals:

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring employs over 7,000 people worldwide. The company has operating subsidiaries in more than 50 countries and markets its products in over 100 countries.

Learn more at www.ferring.com, or connect with us on LinkedIn, Instagram, Facebook, Twitter and YouTube.

The BioInnovation Institute Foundation:

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to EUR 3 million per project and EUR 1,8 million per start-up. With our expertise, network, funding, and infrastructure, we empower start-ups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com.

1 McKinsey & Company. Unlocking opportunities in women’s healthcare. 2022. Available at: https://www.mckinsey.com/industries/healthcare/our-insights/unlocking-opportunities-in-womens-healthcare [Last accessed April 2023]

View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005217/en/

CONTACT:

For more information, please contact:
Ferring Pharmaceuticals
Björn Lindström
Director, Corporate Communications & Public Affairs
+45 28 78 78 62
Bjoern.lindstroem@ferring.com

BioInnovation Institute
Casper Linnemann
Head of Communication
+45 4172 7994
cli@bii.dk

Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health (Photo: Business Wire)


相关文章:
GFO-X Announces Strategic Partnership With LCH SA for Trading and Clearing of Bitcoin Index Futures 
Central Bank of Montenegro Signs Agreement with Ripple to Develop a Digital Currency Strategy and Pi
Rimini Street Expands Scope of Rimini Support for Daekyo to Include Both Oracle and SAP Products Bas
SRMG launches new venture capital arm, SRMG Ventures, with first investments in regional content stu
AMWC 2023: Data From Sculptra Cheek Wrinkle and Alluzience Star Studies Reinforce Strength of Galder
GE Lighting, a Savant Company, Switches from SAP ChaRM to Rimini Watch for Change Management, Achiev
Campbell Lutyens and J.P. Morgan announce strategic collaboration in the secondary advisory market
Rimini Street Formally Launches Rimini ONE, an End-to-End Outsourcing Solution for Enterprise Applic
Ceres Collaborates with Bosch and Linde Engineering on a 1MW Green Hydrogen Demonstration
SES’s Fourth and Fifth C-band Satellites for the United States Successfully Launched
New State of Smart Manufacturing Study Finds Over 40% of Manufacturers Struggle to Outpace Competito
Yugabyte and SRA OSS Announce Strategic Partnership to Accelerate Database Modernization
Galderma Delivers Strong FY 2022 Growth Driven by Innovation and Commercial Performance
Rimini Street Announces Fiscal Fourth Quarter and Annual 2022 Financial and Operational Results
Oral-B Announces Launch of THE BIG RETHINK, an Initiative to Make Oral Care More Inclusive, Accessib
MRM Health Completes Patient Recruitment in Ulcerative Colitis Study, Secures Financing and Provides
Chevron and JERA sign MOU to explore carbon capture and storage projects in United States and Austra
Merck Highlights New Four-Year Efficacy and Safety Data for Investigational BTK Inhibitor, Evobrutin
Luxembourg Announces Intent to Leverage SES’s O3b mPOWER for Europe and NATO
CEOs of Largest Global Companies Positive and Pushing for Growth, Arthur D. Little Research Finds

分享到:
第一金融网免责声明:
1、本网站中的文章(包括转贴文章)的版权仅归原作者所有,若作者有版权声明的或文章从其它网站转载而附带有原所有站的版权声明者,其版权归属以附带声明为准。
2、文章来源为均为其它媒体的转载文章,我们会尽可能注明出处,但不排除来源不明的情况。转载是处于提供更多信息以参考使用或学习、交流、科研之目的,不用于 商业用途。转载无意侵犯版权,如转载文章涉及您的权益等问题,请作者速来电话和函告知,我们将尽快处理。来信:fengyueyoubian#sina.com (请将#改为@)。
3、本网站所载文章、数据、网友投稿等内容纯属作者个人观点,仅供投资者参考,并不构成投资建议,与第一金融网站无关。投资者据此操作,风险自担。如对本文内容有疑义,请及时与我们联系。
相关 Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health 的新闻
发表评论

【发表评论】(网友评论内容只代表网友观点,与本站立场无关!)
 姓 名:
 评 分: 1分 2分 3分 4分 5分
 评论内容:
验证码:   *
  • 请遵守《互联网电子公告服务管理规定》及中华人民共和国其他各项有关法律法规。
  • 严禁发表危害国家安全、损害国家利益、破坏民族团结、破坏国家宗教政策、破坏社会稳定、侮辱、诽谤、教唆、淫秽等内容的评论 。
  • 用户需对自己在使用本站服务过程中的行为承担法律责任(直接或间接导致的)。
  • 本站管理员有权保留或删除评论内容。
  • 评论内容只代表网友个人观点,与本网站立场无关。
  • 全站精选
    [新闻]  机票、酒店、景区都很热!“五一”国内
     央行:加快新型信息基础设施建设 加快金
    [银行]  央行:近期存款利率下调,主要是上次没
     央行:3月份新发放的企业贷款加权平均利
    [股票]  早盘:七大最具爆发潜力的板块和龙头个
     4月21日沪深股市公告与交易提示
    [基金]  证监会、央行:重要货币市场基金持有一
     中国证监会、中国人民银行联合发布《重
    [保险]  银保监会:引导人身保险业为积极应对人
     住院15天必须出院?国家医保局:对住院
    [期货]  白糖期货和现货价格持续上涨 相关概念股
     国家统计局:2023年3月中旬生产资料市场
    [股评]  4月20日A股收评:沪指探底回升收跌0.09
     4月20日A股午评:沪指低开低走半日跌0.
    [港股]  4月20日港股开盘:恒指低开0.06% 恒生科
     港股开盘:恒指低开0.08% 恒生科技指数
    [美股]  今年第6次!特斯拉又降价 涉及这几款车
     美财政部长耶伦:各大银行可能进一步收
    [外汇]  美元指数创近一年新低 在岸、离岸人民币
     3月末我国外汇储备规模为31839亿美元 较
    [债券]  五一节假期 2023法定假日多少天?国债逆
     五一节假日前买国债逆回购有吗?新手怎
    [黄金]  上金所回应“澳铸币厂出售掺杂金条”:
     金荣老师:ATFX交易看对是最好的风控!
    [理财]  五一劳动节股市休市安排(一览)五一股
     “股神”巴菲特:能做这件事,我愿意少
    [信托]  外贸信托观点:谨防清退不“清”新骗局
     赵薇夫妇又怎么了?遭民生信托起诉 还牵
    [房产]  统计局:3月份各线城市商品住宅销售价格
     报告:中国首季40城住房租赁成交量同比
    [汽车]  特斯拉销售回应将降价:谣传
     中汽协:3月汽车产销分别完成258.4万辆

    | 设为首页 | 加入收藏 | 关于我们 | 友情链接 | 版权申明 | 文章列表 | 网站地图 | 征稿启事 | 广告服务 | 意见反馈 |

    Copyright©2006-2027 afinance.cn All Rights Reserved 版权所有·第一金融网 ,未经授权禁止复制或建立镜像,否则将依法追究法律责任!

    声明:我们不做任何形式的代客理财及投资指导,凡是以第一金融网名义做股票推荐的行为均属违法!

    广告商的言论与行为均与第一金融网无关!股市有风险,投资需谨慎。

    合作邮箱:fengyueyoubian@sina.com 合作电话:18678839953  网站QQ:81510603点击这里给我发消息